BIRMINGHAM, Ala.--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) today announced that Stuart Grant, Senior Vice President and Chief Financial Officer of BioCryst, plans to provide a corporate summary and updates regarding its clinical programs for BCX4208, peramivir and forodesine at the Jefferies 2010 Global Life Sciences Conference in New York on June 8, 2010 at 3:30 p.m. Eastern Time.
